stoxline Quote Chart Rank Option Currency Glossary
  
Enovis Corporation (ENOV)
49.96  0.5 (1.01%)    05-30 14:38
Open: 49.38
High: 50.27
Volume: 236,284
  
Pre. Close: 49.46
Low: 49.38
Market Cap: 2,740(M)
Technical analysis
2024-05-30 2:13:20 PM
Short term     
Mid term     
Targets 6-month :  62.55 1-year :  65.91
Resists First :  53.55 Second :  56.43
Pivot price 51.03
Supports First :  48.9 Second :  40.68
MAs MA(5) :  49.88 MA(20) :  51.14
MA(100) :  57.78 MA(250) :  56.01
MACD MACD :  -1.6 Signal :  -1.6
%K %D K(14,3) :  11.8 D(3) :  9
RSI RSI(14): 35.8
52-week High :  66.13 Low :  43.04
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ENOV ] has closed above bottom band by 24.3%. Bollinger Bands are 19.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 49.96 - 50.27 50.27 - 50.49
Low: 48.16 - 48.55 48.55 - 48.83
Close: 48.94 - 49.52 49.52 - 49.92
Company Description

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Headline News

Thu, 30 May 2024
UBS Group AG Acquires 304779 Shares of Enovis Co. (NYSE:ENOV) - Defense World

Wed, 29 May 2024
Enovis Co. (NYSE:ENOV) Receives $75.43 Consensus Price Target from Brokerages - MarketBeat

Tue, 28 May 2024
Wells Fargo & Company MN Buys 503913 Shares of Enovis Co. (NYSE:ENOV) - MarketBeat

Sun, 05 May 2024
Enovis: Solid Growth, But Unstable Financial Footing (NYSE:ENOV) - Seeking Alpha

Fri, 03 May 2024
A Closer Look at 6 Analyst Recommendations For Enovis - Markets Insider

Fri, 03 May 2024
Enovis Corporation (NYSE:ENOV) Q1 2024 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Industrials
Industry:
Industrial - Machinery
Shares Out 55 (M)
Shares Float 50 (M)
Held by Insiders 5.7 (%)
Held by Institutions 107.1 (%)
Shares Short 4,440 (K)
Shares Short P.Month 4,320 (K)
Stock Financials
EPS -1.9
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 60.33
Profit Margin -4.6 %
Operating Margin -3.3 %
Return on Assets (ttm) -0.1 %
Return on Equity (ttm) -3.1 %
Qtrly Rev. Growth 27.1 %
Gross Profit (p.s.) 0
Sales Per Share 33.18
EBITDA (p.s.) 4.3
Qtrly Earnings Growth 0 %
Operating Cash Flow 91 (M)
Levered Free Cash Flow 20 (M)
Stock Valuations
PE Ratio -26.31
PEG Ratio 0.9
Price to Book value 0.82
Price to Sales 1.5
Price to Cash Flow 30
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android